Based on Clarity's multi-model valuation engine, BAXTER INTERNATIONAL INC (BAX) has an estimated fair value of $17.33 per share, compared to its current market price of $16.15. The stock is currently trading 7.3% below Clarity's fair value estimate, resulting in a verdict of FAIR VALUE.

This valuation blends 2 independent models — including Discounted Cash Flow (DCF), EV/Revenue. The primary weight is given to the Discounted Cash Flow (DCF) model, with Bayesian triangulation used to reconcile the estimates into a single blended fair value. The 2 models show very_low agreement with a 95% spread between the highest and lowest estimates.

Monte Carlo simulation across 5,000 scenarios estimates a 43.5% probability that the stock is trading below its intrinsic value, with a median simulated value of $14.67.

Clarity's 1-year price target is $18.86, reflecting expected earnings growth and margin trajectory.

BAXTER INTERNATIONAL INC is classified under the Pharma / Biotech sector, and this valuation is based on 10-K · Filed 2026-02-12 filings sourced directly from SEC EDGAR. All models use trailing twelve month financials where available, with sector-appropriate growth and discount rate assumptions.